A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Clinical trial NCT06267274 · RECRUITING

Trial details

NCT number: NCT06267274
Sponsor: Amneal Pharmaceuticals, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Open-angle Glaucoma Ocular Hypertension

Start date: 2024-04-01
Primary completion: 2025-03-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.